Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Freed Website

Eric O. Freed, Ph.D.

Selected Publications

1)  Freed E, Martin M.
Knipe D, Howley P, eds.
HIVs and their replication. In: Fields Virology, 6th Edition.
Philadelphia: Lippincott, Williams, and Wilkins; 2013. In Press. [Book Chapter]
2)  Afonin KA, Viard M, Martins AN, Lockett SJ, Maciag AE, Freed EO, Heldman E, Jaeger L, Blumenthal R, Shapiro BA.
Activation of different split functionalities on re-association of RNA-DNA hybrids.
Nat Nanotechnol. 2013.
[Journal]
3)  Checkley MA, Luttge BG, Mercredi PY, Kyere SK, Donlan J, Murakami T, Summers MF, Cocklin S, Freed EO.
Reevaluation of the Requirement for TIP47 in Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Incorporation.
J. Virol. 87: 3561-70, 2013.
[Journal]
4)  Keren-Kaplan T, Attali I, Estrin M, Kuo LS, Farkash E, Jerabek-Willemsen M, Blutraich N, Artzi S, Peri A, Freed EO, Wolfson HJ, Prag G.
Structure-based in silico identification of ubiquitin-binding domains provides insights into the ALIX-V:ubiquitin complex and retrovirus budding.
EMBO J. 32: 538-51, 2013.
[Journal]
5)  Kuo L, Freed EO.
ARRDC1 as a mediator of microvesicle budding.
Proc. Natl. Acad. Sci. U.S.A. 109: 4025-6, 2012.
[Journal]
6)  Waheed AA, Freed EO.
HIV Type 1 Gag as a Target for Antiviral Therapy.
AIDS Res. Hum. Retroviruses. 28: 54-75, 2012.
[Journal]
7)  Waki K, Durell SR, Soheilian F, Nagashima K, Butler SL, Freed EO.
Structural and Functional Insights into the HIV-1 Maturation Inhibitor Binding Pocket.
PLoS Pathog. 8: e1002997, 2012.
[Journal]
8)  Matreyek KA, Oztop I, Freed EO, Engelman A.
Viral latency and potential eradication of HIV-1.
Expert Rev Anti Infect Ther. 10: 855-7, 2012.
[Journal]
9)  Lu W, Salzwedel K, Wang D, Chakravarty S, Freed E, Wild C, Li F.
A single polymorphism in HIV-1 subtype C SP-1 is sufficient to confer natural resistance to the maturation inhibitor, bevirimat.
Antimicrob Agents Chemother. 55: 3324-9, 2011.
[Journal]
10)  Zhang H, Curreli F, Zhang X, Bhattacharya S, Waheed AA, Cooper A, Cowburn D, Freed EO, Debnath AK.
Antiviral activity of alpha-helical stapled peptides designed from the HIV-1 capsid dimerization domain.
Retrovirology. 8: 28, 2011.
[Journal]
Click Here to View Expanded Bibliography.

This page was last updated on 4/4/2013.